Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Procaps Group ( (PROCF) ).
On November 19, 2025, Procaps Group announced that it will hold an extraordinary general meeting and an annual general meeting on December 5, 2025. The meetings aim to address significant corporate matters, including a proposed name change to Sofgen Pharma S.A. and the presentation of rectified financial statements for previous years due to past discrepancies. These actions are part of the company’s efforts to ensure transparency and compliance, potentially impacting its market perception and stakeholder trust.
More about Procaps Group
Procaps Group, S.A. is a public limited liability company based in Luxembourg, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products and services, with a focus on developing innovative solutions in the healthcare sector.
Average Trading Volume: 414
Technical Sentiment Signal: Sell
Current Market Cap: $2.93B
For an in-depth examination of PROCF stock, go to TipRanks’ Overview page.